As of 3:59pm ET
| -0.0202 / -3.69%|
The 2 analysts offering 12-month price forecasts for CytRx Corp have a median target of 1.88, with a high estimate of 3.00 and a low estimate of 0.75. The median estimate represents a +255.32% increase from the last price of 0.53.
The current consensus among 2 polled investment analysts is to Buy stock in CytRx Corp. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.